Log in to save to my catalogue

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein oc...

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein oc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd2c9bcca56f4e31af0c31fccc9e3a97

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

About this item

Full title

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

Publisher

England: BMJ Publishing Group Ltd

Journal title

BMJ open ophthalmology, 2021-03, Vol.6 (1), p.e000728-e000728

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectiveTo evaluate the functional benefits (best corrected visual acuity (BCVA), central subfield thickness, injection loads, central venous pressure (CVP)) of a laser-induced chorioretinal anastomosis (L-CRA) in patients with central retinal vein occlusion (CRVO) treated with ranibizumab compared with ranibizumab monotherapy.Methods and Analysis...

Alternative Titles

Full title

Functional benefits of a chorioretinal anastomosis at 2 years in eyes with a central retinal vein occlusion treated with ranibizumab compared with ranibizumab monotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_dd2c9bcca56f4e31af0c31fccc9e3a97

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dd2c9bcca56f4e31af0c31fccc9e3a97

Other Identifiers

ISSN

2397-3269

E-ISSN

2397-3269

DOI

10.1136/bmjophth-2021-000728

How to access this item